Skip to main content

Table 1 Characteristics of IPAH patients and Control group

From: Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension

Parameter (units)

IPAH patients, n=10

Controls, n=8

p

age (years)

41 (37-50)

54 (37-60)

0.24

sex (M)

3 (30 %)

3 (38 %)

0.87

NT-proBNP (pg/ml)

1204 (837-2327)

63 (28.5-135,4)

0.0002

ET-1 (ng/ml)

2.54 (2.06-2.79)

0.63 (0.49-0.86)

0.0002

6MWD (m)

397.5 (345-420)

460 (420-630)

0.02

Hb (g/dl)

15.4 (14.4-16.0)

13.3 (11.8-14.4)

0.01

PAP mean (mmHg)

52 (43-56)

12 (10-14.5)

0.0004

PWP (mmHg)

6 (3-8)

7.5 (6-9.5)

0.35

RAP mean (mmHg)

5 (4-7)

2 (2-3)

0.002

CI (l/min/m2)

1.9 (1.4-2.3)

3.2 (2.5-3.5)

0.002

PAR (dyn*s*cm-5)

1111 (888-1260)

77.9 (32.1-97.6)

0.0004

  1. NT-proBNP N–terminal pro-brain natriuretic peptide, ET-1 endothelin-1, 6MWD six minute walking distance, Hb hemoglobin, PAP mean mean pulmonary arterial pressure, PWP pulmonary wedge pressure, RAP right atrial pressure, CI cardiac index, PAR pulmonary arterial resistance